Median event-free survival (months) stratified by previous treatment and by response to induction therapy (151 randomized patients)
. | Standard treatment; arm A; n = 78 . | Prolonged treatment; arm B; n = 73 . | P . |
|---|---|---|---|
| Chemotherapy naive | 19 | 36 | .009 |
| Pretreated | 10 | 15 | .081 |
| Responders (PR + CR)* | 16 | 36 | .004 |
| Stable disease | 8 | 11 | .35 |
. | Standard treatment; arm A; n = 78 . | Prolonged treatment; arm B; n = 73 . | P . |
|---|---|---|---|
| Chemotherapy naive | 19 | 36 | .009 |
| Pretreated | 10 | 15 | .081 |
| Responders (PR + CR)* | 16 | 36 | .004 |
| Stable disease | 8 | 11 | .35 |
PR indicates partial response; and CR, complete response.
As evaluated at week 12.